Posted by Michael Wonder on 04 May 2017

Cancer drugs are getting better and dearer

The Economist

4 May 2017 - AstraZeneca’s Imfinzi costs $180,000 for a year’s treatment.

Read The Economist article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Cancer , Medicine , US , Pricing